T. Rowe Price Associates
OFIX icon

T. Rowe Price Associates’s Orthofix Medical OFIX Stock Holding History

T. Rowe Price Associates’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$866K Buy
75,437
+12,192
+19% +$161K ﹤0.01% 2227
2025
Q4 		$959K Buy
63,245
+16,556
+35% +$253K ﹤0.01% 2101
2025
Q3 		$684K Buy
46,689
+1,009
+2% +$13.2K ﹤0.01% 2242
2025
Q2 		$510K Buy
45,680
+3,826
+9% +$47.4K ﹤0.01% 2292
2025
Q1 		$683K Buy
41,854
+5,429
+15% +$95.3K ﹤0.01% 2134
2024
Q4 		$636K Buy
36,425
+2,507
+7% +$43.6K ﹤0.01% 2185
2024
Q3 		$530K Buy
33,918
+669
+2% +$10.7K ﹤0.01% 2220
2024
Q2 		$441K Buy
33,249
+292
+0.9% +$4K ﹤0.01% 2241
2024
Q1 		$479K Buy
32,957
+1,236
+4% +$17.1K ﹤0.01% 2229
2023
Q4 		$428K Buy
31,721
+977
+3% +$11.5K ﹤0.01% 2246
2023
Q3 		$396K Sell
30,744
-414
-1% -$7.45K ﹤0.01% 2221
2023
Q2 		$563K Buy
31,158
+459
+1% +$8.57K ﹤0.01% 2073
2023
Q1 		$515K Buy
+30,699
New +$601K ﹤0.01% 2091
2014
Q1 		– Sell
-109,768
Closed -$2.5M – 2512
2013
Q4 		$2.5M Hold
109,768
– – ﹤0.01% 1506
2013
Q3 		$2.29M Sell
109,768
-3,300
-3% -$80.1K ﹤0.01% 1529
2013
Q2 		$3.04M Buy
+113,068
New +$3.39M ﹤0.01% 1476

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates's OFIX Position: Q1 2026 in Review

T. Rowe Price Associates increased its Orthofix Medical (OFIX) stake by 19% in Q1 2026, buying an estimated $161K and bringing the position to 75,437 shares worth $866K. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

T. Rowe Price Associates first reported a position in OFIX in Q2 2013 and has held it in 16 quarters since. The position peaked at $3.04M in Q2 2013. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • T. Rowe Price Associates held 75,437 shares of Orthofix Medical worth $866K as of Q1 2026.
  • T. Rowe Price Associates bought 12,192 Orthofix Medical shares in Q1 2026, an estimated $161K.
  • Orthofix Medical made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2227 holding.
  • T. Rowe Price Associates first reported a position in Orthofix Medical in Q2 2013 and has held it in 16 quarters since.
  • T. Rowe Price Associates's Orthofix Medical position peaked at $3.04M in Q2 2013.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.